SCTL Stock Price, Chart, Stats & News

Societal CDMO, Inc.
Save
116.13M
Market cap
–
Current P/E
–
Forward P/E
SCTL chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 19.54% |
Operating margin | -1.86% |
Pretax margin | -13.89% |
Net margin | -14.03% |
Effective tax rate | -1.00% |
ROA | -8.65% |
ROE | -22.40% |
D/E | 1.39x |
Interest coverage ratio | -0.18x |
SCTL valuation
P/E | – |
P/S | 1.23x |
P/B | 1.79x |
P/CF | -31.38x |
P/FCF | -10.03x |
P/OCF | -31.38x |
PEG | -0.08x |
EV multiple | 6.00x |
About
Societal CDMO, Inc., an organization founded in Exton, Pennsylvania, in 2007, functions as a contract development and manufacturing partner for the global pharmaceutical industry. Formerly known as Recro Pharma, Inc. until its name change in March 2022, the company specializes in supporting small molecule therapeutic advancements. Its comprehensive services span the entire drug development lifecycle, from initial research and development to manufacturing and packaging various therapeutic dosage forms for both domestic and international markets.
Similar securities
Based on sector and market capitalization
Report issue











